{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:27:33Z","timestamp":1777498053120,"version":"3.51.4"},"reference-count":24,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CH"],"published-print":{"date-parts":[[2019,8,5]]},"DOI":"10.3233\/ch-180476","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T11:46:45Z","timestamp":1548762405000},"page":"179-187","source":"Crossref","is-referenced-by-count":3,"title":["TAK733 attenuates adrenergic receptor-mediated cardiomyocyte hypertrophy via inhibiting ErkThr188 phosphorylation"],"prefix":"10.1177","volume":"72","author":[{"given":"Chang Youn","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Integrated Omics for Biomedical Sciences, Yonsei University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyang-Hee","family":"Seo","sequence":"additional","affiliation":[{"name":"Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunhye","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Integrated Omics for Biomedical Sciences, Yonsei University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute for Bio-Medical Convergence, College of Medicine, Catholic Kwandong University, Gangneung, Gangwon-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seahyoung","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute for Bio-Medical Convergence, College of Medicine, Catholic Kwandong University, Gangneung, Gangwon-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soyeon","family":"Lim","sequence":"additional","affiliation":[{"name":"Institute for Bio-Medical Convergence, College of Medicine, Catholic Kwandong University, Gangneung, Gangwon-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Chul","family":"Hwang","sequence":"additional","affiliation":[{"name":"Institute for Bio-Medical Convergence, College of Medicine, Catholic Kwandong University, Gangneung, Gangwon-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"3","key":"10.3233\/CH-180476_ref1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.hlc.2004.06.007","article-title":"Uncovering a hidden epidemic: A study of the current burden of heart failure in Australia","volume":"13","author":"Clark","year":"2004","journal-title":"Heart Lung Circ"},{"issue":"Suppl G","key":"10.3233\/CH-180476_ref2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/eurheartj\/11.suppl_G.54","article-title":"Diastolic function in left ventricular hypertrophy: Clinical and experimental relationships","volume":"11","author":"Lorell","year":"1990","journal-title":"Eur Heart J"},{"issue":"43","key":"10.3233\/CH-180476_ref3","doi-asserted-by":"crossref","first-page":"29109","DOI":"10.1074\/jbc.M802143200","article-title":"Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta","volume":"283","author":"Smeets","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.3233\/CH-180476_ref4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/A:1009885822076","article-title":"Alterations in adrenergic receptor signaling in heart failure","volume":"5","author":"Lamba","year":"2000","journal-title":"Heart Fail Rev"},{"issue":"5","key":"10.3233\/CH-180476_ref5","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"issue":"10","key":"10.3233\/CH-180476_ref6","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/euhj.1998.1093","article-title":"Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study","volume":"19","author":"Vantrimpont","year":"1998","journal-title":"Eur Heart J"},{"issue":"2","key":"10.3233\/CH-180476_ref7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1172\/JCI111023","article-title":"Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response","volume":"72","author":"Simpson","year":"1983","journal-title":"J Clin Invest"},{"issue":"2","key":"10.3233\/CH-180476_ref8","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0021-9258(17)42228-9","article-title":"Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy","volume":"269","author":"Bogoyevitch","year":"1994","journal-title":"J Biol Chem"},{"issue":"2 Pt 2","key":"10.3233\/CH-180476_ref9","first-page":"H625","article-title":"Phenylephrine and endothelin differentially stimulate cardiac PI hydrolysis and ANF expression","volume":"264","author":"McDonough","year":"1993","journal-title":"Am J Physiol"},{"issue":"1","key":"10.3233\/CH-180476_ref10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI116579","article-title":"Endothelin-1 is an autocrine\/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes","volume":"92","author":"Ito","year":"1993","journal-title":"J Clin Invest"},{"issue":"1-2","key":"10.3233\/CH-180476_ref11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11010-017-3140-8","article-title":"microRNA-133a attenuates cardiomyocyte hypertrophy by targeting PKCdelta and Gq","volume":"439","author":"Lee","year":"2018","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"10.3233\/CH-180476_ref12","first-page":"449","article-title":"Alpha 1-adrenoceptors: Subtypes, signaling, and roles in health and disease","volume":"30","author":"Garcia-Sainz","year":"1999","journal-title":"Arch Med Res"},{"issue":"12","key":"10.3233\/CH-180476_ref13","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.biocel.2009.08.002","article-title":"Cardiac hypertrophy: Targeting Raf\/MEK\/ERK1\/2-signaling","volume":"41","author":"Lorenz","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.3233\/CH-180476_ref14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.1893","article-title":"A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy","volume":"15","author":"Lorenz","year":"2009","journal-title":"Nat Med"},{"issue":"33","key":"10.3233\/CH-180476_ref15","doi-asserted-by":"crossref","first-page":"34561","DOI":"10.18632\/oncotarget.5949","article-title":"Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts","volume":"6","author":"Lieu","year":"2015","journal-title":"Oncotarget"},{"key":"10.3233\/CH-180476_ref16","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1038\/bcj.2016.7","article-title":"MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma","volume":"6","author":"de la Puente","year":"2016","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.3233\/CH-180476_ref17","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bmcl.2011.01.071","article-title":"Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer","volume":"21","author":"Dong","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.3233\/CH-180476_ref18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1947601911412376","article-title":"Therapeutic strategies for targeting ras proteins","volume":"2","author":"Gysin","year":"2011","journal-title":"Genes Cancer"},{"issue":"1","key":"10.3233\/CH-180476_ref19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10637-016-0391-2","article-title":"A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors","volume":"35","author":"Adjei","year":"2017","journal-title":"Invest New Drugs"},{"issue":"48","key":"10.3233\/CH-180476_ref20","doi-asserted-by":"crossref","first-page":"37895","DOI":"10.1074\/jbc.M007037200","article-title":"Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy","volume":"275","author":"Yue","year":"2000","journal-title":"J Biol Chem"},{"issue":"7","key":"10.3233\/CH-180476_ref21","doi-asserted-by":"crossref","first-page":"e0159079","DOI":"10.1371\/journal.pone.0159079","article-title":"Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.3233\/CH-180476_ref22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/cvr\/cvr301","article-title":"Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A\/C gene","volume":"93","author":"Muchir","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"18","key":"10.3233\/CH-180476_ref23","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1073\/pnas.1221999110","article-title":"Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy","volume":"110","author":"Ruppert","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.3233\/CH-180476_ref24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/j.1460-2075.1995.tb07076.x","article-title":"ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation","volume":"14","author":"Gille","year":"1995","journal-title":"EMBO J"}],"container-title":["Clinical Hemorheology and Microcirculation"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CH-180476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:07:35Z","timestamp":1777388855000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CH-180476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":24,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/ch-180476","relation":{},"ISSN":["1386-0291","1875-8622"],"issn-type":[{"value":"1386-0291","type":"print"},{"value":"1875-8622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]}}}